Analysts Anticipate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Post $0.67 Earnings Per Share

Wall Street analysts expect DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) to announce $0.67 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for DENTSPLY SIRONA’s earnings. The lowest EPS estimate is $0.61 and the highest is $0.72. DENTSPLY SIRONA reported earnings of $0.72 per share in the same quarter last year, which indicates a negative year over year growth rate of 6.9%. The firm is scheduled to report its next quarterly earnings report before the market opens on Monday, January 1st.

On average, analysts expect that DENTSPLY SIRONA will report full-year earnings of $3.10 per share for the current year, with EPS estimates ranging from $3.01 to $3.17. For the next fiscal year, analysts forecast that the business will post earnings of $3.38 per share, with EPS estimates ranging from $3.15 to $3.49. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last posted its quarterly earnings data on Monday, February 28th. The medical instruments supplier reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.03). DENTSPLY SIRONA had a return on equity of 12.51% and a net margin of 9.90%. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same period in the prior year, the firm posted $0.87 EPS. DENTSPLY SIRONA’s revenue for the quarter was up .6% on a year-over-year basis.

XRAY has been the subject of several research analyst reports. Credit Suisse Group cut their price objective on DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating for the company in a research report on Tuesday, March 1st. StockNews.com started coverage on DENTSPLY SIRONA in a research note on Thursday, March 31st. They set a “buy” rating on the stock. Robert W. Baird cut their price target on DENTSPLY SIRONA from $78.00 to $67.00 and set an “outperform” rating for the company in a report on Friday, February 18th. Barrington Research cut their price target on DENTSPLY SIRONA from $79.00 to $72.00 in a report on Tuesday, March 1st. Finally, HC Wainwright cut their price target on DENTSPLY SIRONA from $66.00 to $58.00 in a report on Tuesday, March 1st. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $66.00.

Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. raised its holdings in shares of DENTSPLY SIRONA by 4.2% in the 4th quarter. BlackRock Inc. now owns 17,700,553 shares of the medical instruments supplier’s stock worth $987,514,000 after buying an additional 709,095 shares in the last quarter. Artisan Partners Limited Partnership raised its holdings in shares of DENTSPLY SIRONA by 0.4% in the 3rd quarter. Artisan Partners Limited Partnership now owns 11,383,822 shares of the medical instruments supplier’s stock worth $660,831,000 after buying an additional 46,064 shares in the last quarter. First Eagle Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 16.5% in the 4th quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock worth $400,796,000 after buying an additional 1,018,179 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in DENTSPLY SIRONA by 15.6% during the 4th quarter. Champlain Investment Partners LLC now owns 5,436,245 shares of the medical instruments supplier’s stock valued at $303,288,000 after purchasing an additional 733,144 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in DENTSPLY SIRONA by 12.2% during the 4th quarter. Invesco Ltd. now owns 4,452,530 shares of the medical instruments supplier’s stock valued at $248,406,000 after purchasing an additional 482,532 shares in the last quarter. 97.32% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ XRAY traded up $0.32 during trading hours on Friday, hitting $49.07. 887,750 shares of the company’s stock were exchanged, compared to its average volume of 1,872,640. DENTSPLY SIRONA has a 1-year low of $47.06 and a 1-year high of $69.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.55 and a quick ratio of 1.12. The stock has a market capitalization of $10.57 billion, a price-to-earnings ratio of 25.56, a PEG ratio of 1.57 and a beta of 0.86. The company’s 50-day moving average price is $51.28 and its 200-day moving average price is $53.53.

The business also recently announced a quarterly dividend, which was paid on Friday, April 8th. Stockholders of record on Friday, March 25th were issued a $0.125 dividend. The ex-dividend date of this dividend was Thursday, March 24th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.02%. DENTSPLY SIRONA’s dividend payout ratio is presently 26.04%.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

See Also

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.